RankAlpha logo
Back to Rankings

CING

CingulateB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Peer-reviewed Phase 3 evidence, ongoing FDA engagement, improved liquidity, and launch preparation create meaningful upside if CTx-1301 advances through approval and commercialization [#PR-EARNINGS-2026-07-30] [#SEC-8K-2026-05-14].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -23.8.
What can break
Commercial manufacturing, payer access, distribution, and launch execution are not yet proven.
Momentum
26
Value
41
Sentiment
83
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.50 · Bull $12.00 · Bear $2.25Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $21.50
Why
Momentum26 · Δ7d +13.2
Value41 · Δ7d -0.0
Sentiment83 · Δ7d -23.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • Sentiment remains the lead driver in the composite, 7D delta -23.8.

Contradictions & invalidation

  • Commercial manufacturing, payer access, distribution, and launch execution are not yet proven.
  • FDA approval and CMC review timing or outcome remain uncertain.
  • The key value inflection remains regulatory approval and CMC execution.

Catalyst clock

2026-07-30

Publication of Phase 3 CTx-1301 ADHD results

Lead driver: Sentiment · See AI snapshot
Momentum
26
9% active weight
Current posture
7d trendImproving
Δ7d
+13.2
Δ21d
+7.8
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
83
62% active weight
Current posture
7d trendSoftening
Δ7d
-23.8
Δ21d
-23.8
Why this grade

Composite grade B. Momentum 26.3 / Value 41.2 / Sentiment 83.4

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method

B+
Bull case
20%
Probability
Target price
$12.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$5.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$2.25
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$75.76M
Beta
-0.77
Shares Out
14.54M
P/E (TTM) · Derived
-1.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-2.11
Rev YoY
-
EPS YoY
-60.8%
Gross Margin
-
Op Margin
-
Net Debt
-$2.17M
Current Ratio
3.50
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data